These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8123625)

  • 1. Human T lymphotropic virus type 1 uveitis.
    Mochizuki M; Tajima K; Watanabe T; Yamaguchi K
    Br J Ophthalmol; 1994 Feb; 78(2):149-54. PubMed ID: 8123625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-lymphotropic virus type I uveitis.
    Yamaguchi K; Mochizuki M; Watanabe T; Miyata N; Tajima K; Mori S; Takatsuki K
    Leukemia; 1994 Apr; 8 Suppl 1():S88-90. PubMed ID: 8152312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T Cell Leukemia Virus Type 1 and Eye Diseases.
    Terada Y; Kamoi K; Komizo T; Miyata K; Mochizuki M
    J Ocul Pharmacol Ther; 2017 May; 33(4):216-223. PubMed ID: 28263674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HTLV-I and ocular disease].
    Ohba N; Nakao K
    Nippon Ganka Gakkai Zasshi; 1993 Apr; 97(4):433-40. PubMed ID: 8317363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell lymphotropic virus type I and neurological diseases.
    Nagai M; Osame M
    J Neurovirol; 2003 Apr; 9(2):228-35. PubMed ID: 12707853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I.
    Mochizuki M; Watanabe T; Yamaguchi K; Takatsuki K; Yoshimura K; Shirao M; Nakashima S; Mori S; Araki S; Miyata N
    Jpn J Cancer Res; 1992 Mar; 83(3):236-9. PubMed ID: 1582883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory manifestations of HTLV-1 and their therapeutic options.
    Martin F; Taylor GP; Jacobson S
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1531-46. PubMed ID: 25340428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis.
    Terada Y; Miyata K; Shoji N; Mochizuki M
    Ocul Immunol Inflamm; 2023 Sep; 31(7):1416-1424. PubMed ID: 36803501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
    Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
    Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
    Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
    Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic diseases in patients with HTLV-1-associated uveitis.
    Nakao K; Abematsu N; Sakamoto T
    Br J Ophthalmol; 2018 Mar; 102(3):373-376. PubMed ID: 28689168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
    Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV infection and the eye.
    Kamoi K; Mochizuki M
    Curr Opin Ophthalmol; 2012 Nov; 23(6):557-61. PubMed ID: 23047174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.